Treatment for beta-blocker poisoning: a systematic review

References

• MIMS Online. In Cardiovascular system – beta-adrenergic blocking agents. Crows Nest, NSW: MIMS Australia Pty Ltd.
   Google Scholar
• Tamargo J, Le Heuzey JY, Mabo P. Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide. Eur J Clin Pharmacol. 2015;71(5):549–567.
   PubMed Web of Science ®Google Scholar
• Lauterbach M. Clinical toxicology of beta-blocker overdose in adults. Basic Clin Pharmacol Toxicol. 2019;125(2):178–186.
   PubMed Web of Science ®Google Scholar
• Gummin DD, Mowry JB, Spyker DA, et al. 2018 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila). 2019;57:1–194.
   PubMed Web of Science ®Google Scholar
• Frishman W, Jacob H, Eisenberg E, et al. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and management. Am Heart J. 1979;98(6):798–811.
   PubMed Web of Science ®Google Scholar
• Frishman WH, Alwarshetty M. Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines. Clin Pharmacokinet. 2002;41(7):505–516.
   PubMed Web of Science ®Google Scholar
• Brouwers MC, for the AGREE Next Steps Consortium, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839–E842.
   PubMed Web of Science ®Google Scholar
• Terracciano L, Brozek J, Compalati E, et al. GRADE system: new paradigm. Curr Opin Allergy Clin Immunol. 2010;10(4):377–383.
   PubMed Web of Science ®Google Scholar
• St-Onge M, Dubé P-A, Gosselin S, et al. Treatment for calcium channel blocker poisoning: a systematic review. Clin Toxicol (Phila). 2014;52(9):926–944.
   PubMed Web of Science ®Google Scholar
• Lavergne V, Nolin TD, Hoffman RS, et al. The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: guideline methodology. Clin Toxicol. 2012;50(5):403–413.
   PubMed Web of Science ®Google Scholar
• Cox D, et al. A comparison of vasopressor utility for drug overdose-induced shock. Clin Toxicol. 2015;53(4):296.
   Web of Science ®Google Scholar
• Robinson HP, et al. Combined therapy with high-dose insulin and vasoactive drugs for beta blocker/calcium channel blocker overdose: characteristics, complications and outcomes. Clin Toxicol. 2015;53(7):651.
   Web of Science ®Google Scholar
• Musselman M, Farber M, Smolinske S, et al. A comparison of high dose insulin therapy and conventional inotropic therapy in calcium channel blocker and/or beta-blocker toxic ingestions. Ann Emerg Med. 2011;58(4):S325.
   Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–349.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US) and National Research Council (US) Committee on the Framework for Evaluating the Safety of Dietary Supplements. Dietary supplements: a framework for evaluating safety. Washington (DC): National Academies Press; 2005.
   Google Scholar
• Moga CGB, Schopflocher D, Harstall C. Development of a Quality Appraisal Tool for case series studies using a modified Delphi technique. Edmonton AB: Institute of Health Economics; 2012.
   Google Scholar
• Kilkenny C, Browne WJ, Cuthill IC, et al. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412.
   PubMed Web of Science ®Google Scholar
• National Research Council. Guidance for the description of animal research in scientific publications. Washington (DC): The National Academies Press; 2011.
   Google Scholar
• Ryan W, Wong A, Graudins A. Analysis of beta blocker and calcium channel blocker overdoses treated with high-dose insulin euglycaemic therapy and/or catecholamine infusion. J Med Toxicol. 2018;14(1):50–51.
   Google Scholar
• Jovic-Stosic J, et al. Antidotal use of intravenous lipid emulsion: 5 years’ experience in an intensive care unit. Clin Toxicol. 2016;54(4):476.
   Web of Science ®Google Scholar
• Cole JB, Stellpflug SJ, Engebretsen KM. Asystole immediately following intravenous fat emulsion for overdose. J Med Toxicol. 2014;10(3):307–310.
   PubMedGoogle Scholar
• Kandil A, Abd-Ellatif M, Abd-Elwahed K. Aversion of the cardiac toxicity of propranolol by atropine. J Drug Res. 1979;11(1–2):17–26.
   Google Scholar
• Tabone D. BET 2: intralipid/lipid emulsion in beta-blocker overdose. Emerg Med J. 2011;28(11):991–993.
   PubMed Web of Science ®Google Scholar
• Meehan TJ, et al. Beta blocker toxicity successfully treated with intravenous fat emulsion: a case series. Clin Toxicol. 2009;47(7):735.
   Web of Science ®Google Scholar
• Cole JB, Stellpflug SJ, Ellsworth H, et al. A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock. Clin Toxicol. 2013;51(4):201–207.
   Web of Science ®Google Scholar
• Langemeijer J, de Wildt D, de Groot G, et al. Calcium interferes with the cardiodepressive effects of beta-blockers overdose in isolated rat hearts. J Toxicol – Clin Toxicol. 1986;24(2):111–133.
   PubMed Web of Science ®Google Scholar
• Jacques AC. Case series of hyperinsulinaemic euglycaemic therapy and lipid emulsion therapy in self-poisoning with calcium channel antagonists or beta-blockers. J Intensive Care Soc. 2014;15(1 suppl):S20–S21.
   Google Scholar
• Mithani S, Dong K, Wilmott A, et al. A cohort study of unstable overdose patients treated with intravenous lipid emulsion therapy. CJEM Can J Emerg Med Care. 2017;19(04):256–264.
   Google Scholar
• Sato S, Tsuji MH, Okubo N, et al. Combined use of glucagon and milrinone may not be preferable for severe propranolol poisoning in the canine model. J Toxicol – Clin Toxicol. 1995;33(4):337–342.
   PubMed Web of Science ®Google Scholar
• Love JN, Leasure JA, Mundt DJ, et al. A comparison of amrinone and glucagon therapy for cardiovascular depression associated with propranolol toxicity in a canine model. J Toxicol – Clin Toxicol. 1992;30(3):399–412.
   PubMed Web of Science ®Google Scholar
• Masson R, Colas V, Parienti J-J, et al. A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation. 2012;83(11):1413–1417.
   PubMed Web of Science ®Google Scholar
• Holger JS, Engebretsen KM, Obetz CL, et al. A comparison of vasopressin and glucagon in beta-blocker induced toxicity. Clin Toxicol: Off J Am Acad Clin Toxicol Eur Assoc Poisons Centres Clin Toxicologists. 2006;44(1):45–51.
   Google Scholar
• Rials SJ, Tse WW. Effects of atropine on cardiac arrest induced by propranolol and digitoxin. Federation Proc. 1979;38 (3 II):4695.
   Google Scholar
• Megarbane B, Leprince P, Deye N, et al. Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest. Intensive Care Med. 2007;33(5):758–764.
   PubMed Web of Science ®Google Scholar
• Daubin C, Lehoux P, Ivascau C, et al. Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases. Crit Care. 2009;13(4):R138.
   PubMed Web of Science ®Google Scholar
• Kosinski EJ, Malindzak GS Jr. Glucagon and isoproterenol in reversing propranolol toxicity. Arch Intern Med. 1973;132(6):840–843.
   PubMedGoogle Scholar
• Love JN, Hanfling D, Howell JM. Hemodynamic effects of calcium chloride in a canine model of acute propranolol intoxication. Ann Emerg Med. 1996;28(1):1–6.
   PubMed Web of Science ®Google Scholar
• Cole JB, Arens AM, Laes JR, et al. High dose insulin for beta-blocker and calcium channel-blocker poisoning: 17 years of experience from a single poison center. Am J Emerg Med. 2018;06:06.
   Google Scholar
• Pozzi M, Koffel C, Djaref C, et al. High rate of arterial complications in patients supported with extracorporeal life support for drug intoxication-induced refractory cardiogenic shock or cardiac arrest. J Thorac Dis. 2017;9(7):1988–1996.
   PubMed Web of Science ®Google Scholar
• Doepker B, Healy W, Cortez E, et al. High-dose insulin and intravenous lipid emulsion therapy for cardiogenic shock induced by intentional calcium-channel blocker and Beta-blocker overdose: a case series. J Emerg Med. 2014;46(4):486–490.
   PubMed Web of Science ®Google Scholar
• Holger JS, Stellpflug SJ, Cole JB, et al. High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock. Clin Toxicol: Off J Am Acad Clin Toxicol Eur Assoc Poisons Centres Clin Toxicologists. 2011;49(7):653–658.
   Google Scholar
• Kerns W, Schroeder‡ D, Williams‡ C 2nd, et al. Insulin improves survival in a canine model of acute beta-blocker toxicity. Ann Emerg Med. 1997;29(6):748–757.
   PubMed Web of Science ®Google Scholar
• Harvey M, Cave G, Lahner D, et al. Insulin versus lipid emulsion in a rabbit model of severe propranolol toxicity: a pilot study. Crit Care Res Pract. 2011;2011:1–7.
   Google Scholar
• Holger JS, Engebretsen KM, Fritzlar SJ, et al. Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity. Clin Toxicol: Off J Am Acad Clin Toxicol Eur Assoc Poisons Centres Clin Toxicologists. 2007;45(4):396–401.
   Google Scholar
• Eren Cevik S, Tasyurek T, Guneysel O. Intralipid emulsion treatment as an antidote in lipophilic drug intoxications. Am J Emerg Med. 2014;32(9):1103–1108.
   PubMed Web of Science ®Google Scholar
• Harvey MG, Cave GR. Intralipid infusion ameliorates propranolol-induced hypotension in rabbits. J Med Toxicol. 2008;4(2):71–76.
   PubMedGoogle Scholar
• Kalam Y, Graudins A. Intravenous fructose-1,6-diphosphate improves survival and blood pressure in propranolol-poisoned rodents. Clin Toxicol. 2012;50(7):546–554.
   Web of Science ®Google Scholar
• Browne A, Harvey M, Cave G. Intravenous lipid emulsion does not augment blood pressure recovery in a rabbit model of metoprolol toxicity. J Med Toxicol. 2010;6(4):373–378.
   PubMedGoogle Scholar
• Gunaydin YK. Intravenous lipid emulsion therapy in calcium channel blocker and beta-blocker poisoning. Notfall Und Rettungsmedizin. 2017;20(1):54–60.
   Web of Science ®Google Scholar
• Kalam Y, Graudins A. Levosimendan does not improve cardiac output or blood pressure in a rodent model of propranolol toxicity when administered using various dosing regimens. Int J Toxicol. 2012;31(2):166–174.
   PubMed Web of Science ®Google Scholar
• Kalam Y, Graudins A. Levosimendan infusion improves cardiac output but not blood pressure in a rodent model of severe metoprolol toxicity. Hum Exp Toxicol. 2012;31(9):955–963.
   PubMed Web of Science ®Google Scholar
• Cave G, Harvey M. Lipid emulsion may augment early blood pressure recovery in a rabbit model of atenolol toxicity. J Med Toxicol. 2009;5(1):50–51.
   PubMedGoogle Scholar
• Sato S, Tsuji MH, Okubo N, et al. Milrinone versus glucagon: comparative hemodynamic effects in canine propranolol poisoning. J Toxicol – Clin Toxicol. 1994;32(3):277–289.
   PubMed Web of Science ®Google Scholar
• Totterman KJ, Turto H, Pellinen T. Overdrive pacing as treatment of sotalol induced ventricular tachyarrhythmias (torsade de pointes). Acta Med Scand. 2009;212(S668):28–33.
   Google Scholar
• Gerwin H, Behrman A, Goetz R, et al. Predictors of response to insulin, glucagon, and lipid emulsion in antihypertensive overdose. Crit Care Med. 2015;43(1):32.
   Google Scholar
• Andersson T, Heath A, Mattsson H. Prenalterol as an antidote to massive doses of metoprolol –a cardiovascular study in the dog. Acta Med Scand. 2009;211(S659):71–88.
   Google Scholar
• Katzung KG, Leroy JM, Boley SP, et al. A randomized controlled study comparing high-dose insulin to vasopressors or combination therapy in a porcine model of refractory propranolol-induced cardiogenic shock. Clin Toxicol (Phila). 2019;57:1–7.
   PubMed Web of Science ®Google Scholar
• Whitehurst VE, Joseph X, Vick JA, et al. Reversal of propranolol and verapamil toxicity by calcium. Vet Hum Toxicol. 1996;110(1–3):110–113.
   Google Scholar
• Cave G, Harvey MG, Castle CD. The role of fat emulsion therapy in a rodent model of propranolol toxicity: a preliminary study. J Med Toxicol. 2006;2(1):4–7.
   PubMedGoogle Scholar
• Sebe A, Dişel NR, Açıkalın Akpınar A, et al. Role of intravenous lipid emulsions in the management of calcium channel blocker and beta-blocker overdose: 3 years experience of a university hospital. Postgrad Med. 2015;127(2):119–124.
   PubMed Web of Science ®Google Scholar
• Page CB, Ryan NM, Isbister GK. The safety of high-dose insulin euglycaemia therapy in toxin-induced cardiac toxicity. Clin Toxicol: Off J Am Acad Clin Toxicol Eur Assoc Poisons Centres Clin Toxicologists. 2018;56(6):389–396.
   Google Scholar
• Babatasi G, Massetti M, Verrier V, et al. Severe intoxication with cardiotoxic drugs: value of emergency percutaneous cardiocirculatory assistance. Arch Mal Coeur Vaiss. 2001;94(12):1386–1392.
   PubMedGoogle Scholar
• Riggan M, McLeod SL, Hames H. The use of intralipid and high dose insulin therapy in the emergency department management of beta blocker and calcium channel blocker toxicity. Can J Emerg Med. 2014;16 (Supp 1):S52.
   Google Scholar
• Darracq MA, Thornton SL, Do HM, et al. Utilization of hyperinsulinemia euglycemia and intravenous fat emulsion following poison center recommendations. J Med Toxicol. 2013;9(3):226–230.
   PubMedGoogle Scholar
• Catlin J, et al. Weight-based dosing for intravenous glucagon bolus is associated with chronotropic response in beta-blocker toxicity. J Med Toxicol. 2018;14(1):53.
   Google Scholar
• Smolinske S, Hoffman RS, Villeneuve E, et al. Observational study on the use of methylene blue for shock in fatal overdoses. Clin Toxicol. 2019;57(3):197–202.
   PubMed Web of Science ®Google Scholar
• Harley C, Kannan S, Morrow B. Combined overdose with bisoprolol, nifedipine and diltiazem. Care Crit Ill. 2001;17(2):65–66.
   Google Scholar
• Abbasi IA, Sorsby S. Prolonged toxicity from atenolol overdose in an adolescent. Clin Pharm. 1986;5(10):836–837.
   PubMedGoogle Scholar
• Amundson DE, Brodine SK. A fatal case of propranolol poisoning. Drug Intell Clin Pharm. 1988;22(10):781–782.
   PubMedGoogle Scholar
• Henry M, Kay MM, Viccellio P. Cardiogenic shock associated with calcium-channel and beta blockers: reversal with intravenous calcium chloride. Am J Emerg Med. 1985;3(4):334–336.
   PubMed Web of Science ®Google Scholar
• Pertoldi F, D'Orlando L, Mercante WP. Electromechanical dissociation 48 hours after atenolol overdose: usefulness of calcium chloride. Ann Emerg Med. 1998;31(6):777–781.
   PubMed Web of Science ®Google Scholar
• Barton CA, Johnson NB, Mah ND, et al. Successful treatment of a massive metoprolol overdose using intravenous lipid emulsion and hyperinsulinemia/euglycemia therapy. Pharmacotherapy. 2015;35(5):e56–e60.
   PubMed Web of Science ®Google Scholar
• Czerwonka E, Heim M. Lipid rescue therapy and hyperinsulinemia/euglycemia for atenolol and zolpidem overdose. Crit Care Med. 2015;43 (12 (supplement 1):316.
   Web of Science ®Google Scholar
• Markota A, Hajdinjak E, Rupnik B, et al. Treatment of near-fatal beta blocker and calcium channel blocker intoxication with hyperinsulinemic euglycemia, intravenous lipid emulsions and high doses of norepinephrine. Signa Vitae. 2015;10(1):144–150.
   Web of Science ®Google Scholar
• Qureshi M, Catalasan G. The use of high dose insulin euglycemia therapy in calcium channel blocker and beta blocker overdose. J Gen Intern Med. 2016;31(2 Supplement):S760–S761.
   Google Scholar
• Seegobin K, Maharaj S, Deosaran A, et al. Severe beta blocker and calcium channel blocker overdose: role of high dose insulin. Am J Emerg Med. 2018;36(4):736.e5–736.e6.
   Web of Science ®Google Scholar
• Ray S, Garg A, Singh VK, et al. Severe suicidal digoxin and propranolol toxicity with insulin overdose: a case report. Indian J Crit Care Med. 2014;18(3):173–175.
   PubMedGoogle Scholar
• Bouchard NC, Forde J, Hoffman RS. Carvedilol overdose with quantitative confirmation. Basic Clin Pharmacol Toxicol. 2008;103(1):102–103.
   PubMed Web of Science ®Google Scholar
• Fung HT, Lai CH, Wong OF, et al. The use of glucagon and other antidotes in a case of beta-blocker and calcium channel blocker overdose. Hong Kong J Emerg Med. 2007;14(2):113–118.
   Google Scholar
• Kacirova I, Grundmann M, Kolek M, et al. Lethal suicide attempt with a mixed-drug intoxication of metoprolol and propafenone –a first pediatric case report. Forensic Sci Int. 2017;278:e34–e40.
   PubMed Web of Science ®Google Scholar
• Kolcz J, Pietrzyk J, Januszewska K, et al. Extracorporeal life support in severe propranolol and verapamil intoxication. J Intensive Care Med. 2007;22(6):381–385.
   PubMedGoogle Scholar
• Murphy NG, et al. Early use of high dose insulin-glucose euglycemia prevents hemodynamic instability after metoprolol overdose. Clin Toxicol. 2010;48(6):648.
   Web of Science ®Google Scholar
• Paetow GM, et al. Use of tissue perfusion monitoring to titrate high dose insulin in beta blocker and calcium channel blocker overdose. Clin Toxicol. 2015;53(7):705–706.
   Web of Science ®Google Scholar
• Tai YT, Lo CW, Chow WH, et al. Successful resuscitation and survival following massive overdose of metoprolol. Br J Clin Pract. 1990;44(12):746–747.
   PubMedGoogle Scholar
• Salzberg MR, Gallagher EJ. Propranolol overdose. Ann Emerg Med. 1980;9(1):26–27.
   PubMed Web of Science ®Google Scholar
• Heise CW, Beutler D, Bosak A, et al. Massive atenolol, lisinopril, and chlorthalidone overdose treated with endoscopic decontamination, hemodialysis, impella percutaneous left ventricular assist device, and ECMO. J Med Toxicol. 2015;11(1):110–114.
   PubMed Web of Science ®Google Scholar
• Jones JW, Clark MA, Mullen BL. Suicide by ingestion of propranolol. J Forensic Sci. 1982;27(1):213–216.
   PubMed Web of Science ®Google Scholar
• Bourg PW, McLarnon A. Propranolol overdose. J Emerg Nurs. 1982;8(6):275–276.
   PubMedGoogle Scholar
• Bourgine J, et al. Acute poisoning with sustained release propranolol and acetaminophen: delayed effects. Fundam Clin Pharmacol. 2014;28 (supp 1):98.
   Google Scholar
• Halloran TJ, Phillips CE. Propranolol intoxication. A severe case responding to norepinephrine therapy. Arch Intern Med. 1981;141(6):810–811.
   PubMedGoogle Scholar
• Hopkins LE, Sunkersing J, Jacques A. Too many pills to swallow: a case of a mixed overdose. J Intensive Care Soc. 2017;18(3):247–250.
   PubMedGoogle Scholar
• Lewis M, Kallenbach J, Germond C, et al. Survival following massive overdose of adrenergic blocking agents (acebutolol and labetalol). Eur Heart J. 1983;4(5):328–332.
   PubMed Web of Science ®Google Scholar
• Jones JL. Metoprolol overdose. Ann Emerg Med. 1982;11(2):114–115.
   PubMed Web of Science ®Google Scholar
• O’Grady J, Anderson S, Pringle D. Successful treatment of severe atenolol overdose with calcium chloride. CJEM Can J Emerg Med Care. 2001;3(03):224–227.
   Google Scholar
• Cole JB, et al. High dose insulin for beta blocker and calcium channel blocker poisoning: assessment of feasibility and metabolic abnormalities from 17 years of experience from a single poison center. Acad Emerg Med. 2018;25 (Supplement 1):S216–S217.
   Google Scholar
• Page C, Hacket LP, Isbister GK. The use of high-dose insulin-glucose euglycemia in beta-blocker overdose: a case report. J Med Toxicol. 2009;5(3):139–143.
   PubMedGoogle Scholar
• Love JN, Elshami J. Cardiovascular depression resulting from atenolol intoxication. Eur J Emerg Med. 2002;9(2):111–114.
   PubMedGoogle Scholar
• DeLima LG, Kharasch ED, Butler S. Successful pharmacologic treatment of massive atenolol overdose: sequential hemodynamics and plasma atenolol concentrations. Anesthesiology. 1995;83(1):204–207.
   PubMed Web of Science ®Google Scholar
• Mansell PI. Glucagon in the management of deliberate self-poisoning with propranolol. Arch Emerg Med. 1990;7(3):238–240.
   PubMedGoogle Scholar
• O'Mahony D, O'Leary P, Molloy MG. Severe oxprenolol poisoning: the importance of glucagon infusion. Hum Exp Toxicol. 1990;9(2):101–103.
   PubMed Web of Science ®Google Scholar
• Khan MI, Miller MT. Beta-blocker toxicity–the role of glucagon. Report of 2 cases.[Erratum appears in S Afr Med J 1986 Jul 19;70(2):124]. S Afr Med J. Suid-Afrikaanse Tydskrif Vir Geneeskunde. 1985;67(26):1062–1063.
   PubMed Web of Science ®Google Scholar
• Ward DE, Jones B. Glucagon and beta-blocker toxicity. Br Med J. 1976;2(6028):151.
   PubMedGoogle Scholar
• Khan MI, Miller MT. Beta-blocker toxicity –the role of glucagon. Report of 2 cases. S Afr Med J. 1985;67(26):1062–1063.
   PubMed Web of Science ®Google Scholar
• Aggarwal N, Kupfer Y, Seneviratne C, et al. Methylene blue reverses recalcitrant shock in beta-blocker and calcium channel blocker overdose. BMJ Case Rep. 2013;2013 (1):bcr2012007402.
   PubMedGoogle Scholar
• Kim HK, et al. Methylene blue for refractory hypotension in cardiovascular drug overdose. Clin Toxicol. 2012;50(4):365.
   Web of Science ®Google Scholar
• Laes JR, et al. Hemodynamic changes after methylene blue administration in poison-induced shock. Clin Toxicol. 2014;52(7):753.
   Web of Science ®Google Scholar
• Laes JR, Williams DM, Cole JB. Improvement in hemodynamics after methylene blue administration in drug-induced vasodilatory shock: a case report. J Med Toxicol. 2015;11(4):460–463.
   PubMed Web of Science ®Google Scholar
• Biary R, et al. Intravenous lipid emulsion used in the therapy of a patient with prolonged cardiac pauses following a single pill ingestion of propafenone. Clin Toxicol. 2014;52(4):405.
   Web of Science ®Google Scholar
• Carr D, et al. Successful resuscitation of a carvedilol overdose using intravenous fat emulsion (IFE). Clin Toxicol. 2009;47(7):727.
   Web of Science ®Google Scholar
• Cumpston KL, Gopaul R, Wills B. Adjunctive use of low-dose intralipid associated with hemodynamic improvement in combined amlodipine and labetalol overdose refractory to standard therapy. Am J Ther. 2017;24(4):e485.
   PubMed Web of Science ®Google Scholar
• Dean P, Ruddy JP, Marshall S. Intravenous lipid emulsion in propranolol overdose. Anaesthesia. 2010;65(11):1148–1150.
   PubMed Web of Science ®Google Scholar
• Escajeda JT, Katz KD, Rittenberger JC. Successful treatment of metoprolol-induced cardiac arrest with high-dose insulin, lipid emulsion, and ECMO. Am J Emerg Med. 2015;33(8): 1111.e1–4.
   Web of Science ®Google Scholar
• Johnson-Arbor K, Salinger L, Luczycki S. Prolonged laboratory interference after administration of intravenous lipid emulsion therapy. J Med Toxicol. 2015;11(2):223–226.
   PubMed Web of Science ®Google Scholar
• Jovic-Stosic J, Gligic B, Putic V, et al. Severe propranolol and ethanol overdose with wide complex tachycardia treated with intravenous lipid emulsion: a case report. Clin Toxicol: Off J Am Acad Clin Toxicol Eur Assoc Poisons Centres Clin Toxicologists. 2011;49(5):426–430.
   Google Scholar
• Macala K, Bandrauk N, Smith A. Fatty emulsion: surviving clonidine & propranolol overdose. Can J Anesthesia. 2013;60(1):S66.
   Google Scholar
• Orthober R, Huecker M, Sandlin D, et al. Polypharmacy overdose in a 36-year-old man. Air Med J. 2013;32(1):4.
   Google Scholar
• Pasha A, Kazmi S, Ehtesham M. Is fat always bad? A case study demonstrating the lifesaving effect of lipid emulsion therapy in beta blocker and calcium channel blocker overdose. Chest. 2017;152(4):A259.
   Web of Science ®Google Scholar
• Rodriguez B, Wilhelm A, Kokko KE. Lipid emulsion use precluding renal replacement therapy. J Emerg Med. 2014;47(6):635–637.
   PubMed Web of Science ®Google Scholar
• Stellpflug SJ, Harris CR, Engebretsen KM, et al. Overdose of diltiazem, metoprolol, and amiodarone treated successfully with intravenous fat emulsion and high dose insulin in an awake patient. Clin Toxicol. 2010;48(3):227–229.
   Web of Science ®Google Scholar
• Stellpflug SJ, Fritzlar SJ, Cole JB, et al. Cardiotoxic overdose treated with intravenous fat emulsion and high-dose insulin in the setting of hypertrophic cardiomyopathy. J Med Toxicol. 2011;7(2):151–153.
   PubMedGoogle Scholar
• Troendle MM, et al. Adjunctive use of low dose intralipid associated with hemodynamic improvement in combined amlodipine and labetalol overdose refractory to standard therapy. Clin Toxicol. 2013;51(7):650–651.
   Web of Science ®Google Scholar
• Thompson AM, Franco Palacios CR, Henriksen MN. Intravenous lipid emulsion and high-dose insulin as adjunctive therapy for propranolol toxicity in a pediatric patient. Am J Health-Syst Pharm. 2016;73(12):880–885.
   PubMed Web of Science ®Google Scholar
• Walter E, McKinlay J, Corbett J, et al. Review of management in cardiotoxic overdose and efficacy of delayed intralipid use. J Intensive Care Soc. 2018;19(1):50–55.
   PubMedGoogle Scholar
• Levine M, for the Lipid Emulsion Workgroup, Hoffman RS, Lavergne V, et al. Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity. Clin Toxicol. 2016;54(3):194–221.
   PubMed Web of Science ®Google Scholar
• Hayes BD, Lipid Emulsion Workgroup, Gosselin S, Calello DP, et al. Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration. Clin Toxicol (Phila). 2016;54(5):365–404.
   PubMed Web of Science ®Google Scholar
• Assimes TL, Malcolm I. Torsade de pointes with sotalol overdose treated successfully with lidocaine. Can J Cardiol. 1998;14(5):753–756.
   PubMed Web of Science ®Google Scholar
• Belton P, Sheridan J, Mulcahy R. A case of sotalol poisoning. Ir J Med Sci. 1982;151(1):126–127.
   PubMedGoogle Scholar
• Edvardsson N, Varnauskas E. Clinical course, serum concentrations and elimination rate in a case of massive sotalol intoxication. Eur Heart J. 1987;8(5):544–548.
   PubMed Web of Science ®Google Scholar
• Sandroni C, Cavallaro F, Caricato A, et al. Enoximone in cardiac arrest caused by propranolol: two case reports. Acta Anaesthesiol Scand. 2006;50(6):759–761.
   PubMed Web of Science ®Google Scholar
• Sandroni C, Cavallaro F, Addario C, et al. Successful treatment with enoximone for severe poisoning with atenolol and verapamil: a case report. Acta Anaesthesiol Scand. 2004;48(6):790–792.
   PubMed Web of Science ®Google Scholar
• Shanker UR, Webb J, Kotze A. Sodium bicarbonate to treat massive beta blocker overdose. Emerg Med J. 2003;20(4):393.
   PubMed Web of Science ®Google Scholar
• Hoeper MM, Boeker KH. Overdose of metoprolol treated with enoximone. N Engl J Med. 1996;335(20):1538–1539.
   PubMed Web of Science ®Google Scholar
• Kollef MH. Labetalol overdose successfully treated with amrinone and alpha-adrenergic receptor agonists. Chest. 1994;105(2):626–627.
   PubMed Web of Science ®Google Scholar
• Hurwitz MD, Kallenbach JM, Pincus PS. Massive propranolol overdose. Am J Med. 1986;81(6):1118.
   PubMed Web of Science ®Google Scholar
• Freestone S, Thomas HM, Bhamra RK, et al. Severe atenolol poisoning: treatment with prenalterol. Hum Toxicol. 1986;5(5):343–345.
   PubMedGoogle Scholar
• Agura ED, Wexler LF, Witzburg RA. Massive propranolol overdose. Successful treatment with high-dose isoproterenol and glucagon. Am J Med. 1986;80(4):755–757.
   Web of Science ®Google Scholar
• Wallin CJ, Hulting J. Massive metoprolol poisoning treated with prenalterol. Acta Med Scand. 2009;214(3):253–255.
   Google Scholar
• Pfaender M, Casetti PG, Azzolini M, et al. Successful treatment of a massive atenolol and nifedipine overdose with CVVHDF. Minerva Anestesiol. 2008;74(3):97–100.
   PubMed Web of Science ®Google Scholar
• Huang S-HS, Tirona RG, Ross C, et al. Case report: atenolol overdose successfully treated with hemodialysis. Hemodial Int. 2013;17(4): n/a–5.
   Web of Science ®Google Scholar
• Singh SN, Lazin A, Cohen A, et al. Sotalol-induced torsades de pointes successfully treated with hemodialysis after failure of conventional therapy. Am Heart J. 1991;121(2):601–602.
   PubMed Web of Science ®Google Scholar
• Anthony T, Jastremski M, Elliott W, et al. Charcoal hemoperfusion for the treatment of a combined diltiazem and metoprolol overdose. Ann Emerg Med. 1986;15(11):1344–1348.
   PubMed Web of Science ®Google Scholar
• Megarbane B, Deye N, Baud FJ. Extracorporeal life support for poisonings with cardiotoxicants [French]. Revue du Praticien. 2008;58(8):855–860.
   PubMedGoogle Scholar
• Bilbault P, Pynn S, Mathien C, et al. Near-fatal betaxolol self-poisoning treated with percutaneous extracorporeal life support. Eur J Emerg Med. 2007;14(2):120–122.
   PubMed Web of Science ®Google Scholar
• Chenoweth JA, Colby DK, Sutter ME, et al. Massive diltiazem and metoprolol overdose rescued with extracorporeal life support. Am J Emerg Med. 2017;35(10):1581.e3–1581.e5.
   Web of Science ®Google Scholar
• De Rita F, Barozzi L, Franchi G, et al. Rescue extracorporeal life support for acute verapamil and propranolol toxicity in a neonate. Artif Organs. 2011;35(4):416–420.
   PubMed Web of Science ®Google Scholar
• Maskell KF, Ferguson NM, Bain J, et al. Survival after cardiac arrest: ECMO rescue therapy after amlodipine and metoprolol overdose. Cardiovasc Toxicol. 2017;17(2):223–225.
   PubMed Web of Science ®Google Scholar
• Rona R, Cortinovis B, Marcolin R, et al. Extra-corporeal life support for near-fatal multi-drug intoxication: a case report. J Med Case Rep. 2011;5(1):231.
   PubMedGoogle Scholar
• Lane AS, Woodward AC, Goldman MR. Massive propranolol overdose poorly responsive to pharmacologic therapy: use of the intra-aortic balloon pump. Ann Emerg Med. 1987;16(12):1381–1383.
   PubMed Web of Science ®Google Scholar
• Janion M, Stępień A, Sielski J, et al. Is the intra-aortic balloon pump a method of brain protection during cardiogenic shock after drug intoxication? J Emerg Med. 2010;38(2):162–167.
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Neumann F-J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287–1296.
   PubMed Web of Science ®Google Scholar
• Thomas SH, Behr ER. Pharmacological treatment of acquired QT prolongation and torsades de pointes. Br J Clin Pharmacol. 2016;81(3):420–427.
   PubMed Web of Science ®Google Scholar
• Litman RS, Zerngast BA. Cardiac arrest after esmolol administration: a review of acute beta-blocker toxicity. J Am Osteopath Assoc. 1996;96(10):616–618.
   PubMedGoogle Scholar
• Hicks PR, Rankin AP. Massive adrenaline doses in labetalol overdose. Anaesth Intensive Care. 1991;19(3):447–449.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Ang K, Gorman K, et al. Zero-order metoprolol pharmacokinetics after therapeutic doses: severe toxicity and cardiogenic shock. Clin Toxicol: Off J Am Acad Clin Toxicol Eur Assoc Poisons Centres Clin Toxicologists. 2016;54(9):881–885.
   Google Scholar
• Kalman S, Berg S, Lisander B. Combined overdose with verapamil and atenolol: treatment with high doses adrenergic agonists. Acta Anaesthesiol Scand. 1998;42(3):379–382.
   PubMed Web of Science ®Google Scholar
• Jones B, Jacobsen D, Helgeland A, et al. Treatment of beta-blocker poisoning. Lancet. 1980;315(8176):1031–1032.
   Google Scholar
• Doepker B, Cortez E, Healy W, et al. High dose insulin and lipid emulsion therapy for cardiogenic shock: a case series. Crit Care Med. 2013;41 (12 (supplement 1)):A308–A309.
   Web of Science ®Google Scholar
• Hasin T, Leibowitz D, Antopolsky M, et al. The use of low-dose insulin in cardiogenic shock due to combined overdose of verapamil, enalapril and metoprolol. Cardiology. 2006;106(4):233–236.
   PubMed Web of Science ®Google Scholar
• Montague AJ, et al. High dose insulin to treat propranolol toxicity in a 7-month-old infant. Clin Toxicol. 2015;53(7):740.
   Web of Science ®Google Scholar
• Singh S, Singh S, Chittivelu S. Is using high dose insulin in lieu of glucagon in beta blocker toxicity a good idea? Chest. Conference: CHEST. 2015;148(4):275A (4 MEETING ABSTRACT).
   Web of Science ®Google Scholar
• Cole JB, et al. Failure of high dose insulin and intravenous fat emulsion in 2 patients with poison-induced cardiogenic shock. Clin Toxicol. 2011;49(6):537–538.
   Web of Science ®Google Scholar
• Cole JB, Stellpflug SJ, Ellsworth H, et al. A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock.[Erratum appears in Clin Toxicol (Phila). 2013 Dec;51(10):1246]. Clin Toxicol: Off J Am Acad Clin Toxicol Eur Assoc Poisons Centres Clin Toxicologists. 2013;51(4):201–207.
   Google Scholar
• Fernandes CM, Daya MR. Sotalol-induced bradycardia reversed by glucagon. Can Fam Physician. 1995;41: 659–660, 663.
   PubMed Web of Science ®Google Scholar
• Rooney M, Massey KL, Jamali F, et al. Acebutolol overdose treated with hemodialysis and extracorporeal membrane oxygenation. J Clin Pharmacol. 1996;36(8):760–763.
   PubMed Web of Science ®Google Scholar
• Rygnestad T, Moen S, Wahba A, et al. Severe poisoning with sotalol and verapamil. Recovery after 4 h of normothermic CPR followed by extra corporeal heart lung assist. Acta Anaesthesiol Scand. 2005;49(9):1378–1380.
   PubMed Web of Science ®Google Scholar
• Nordmark Grass J, Ahlner J, Kugelberg FC, et al. A case of massive metoprolol and amlodipine overdose with blood concentrations and survival following extracorporeal corporeal membrane oxygenation (ECMO). Clin Toxicol: Off J Am Acad Clin Toxicol Eur Assoc Poisons Centres Clin Toxicologists. 2019;57(1):66–68.
   Google Scholar